PLUR
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Stock is fundamentally overvalued relative to its negative book value and low revenue.
- P/B is -2.40
- P/S is 26.35
- No Graham Number available due to negative earnings
Growth is insufficient to offset the current rate of capital depletion.
- Improving EPS trend
- Positive revenue growth
- Low revenue growth (7%) compared to sector average
- High burn rate
Long-term performance shows a consistent downward trajectory.
- 5Y Change: -89.3%
- Consistent history of negative earnings
Financial health is in a critical state; high probability of needing emergency capital.
- Piotroski F-Score 1/9
- Current Ratio 0.43
- Negative Equity
Dividend strength is 0/100.
- No dividend paid
- No capacity for dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for PLUR and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
PLUR
Pluri Inc.
Primary
|
-89.3% | -51.8% | -3.0% | -19.3% | +8.7% | +3.5% |
|
LGVN
Longeveron Inc.
Peer
|
-98.3% | -96.0% | -14.1% | +42.7% | +42.7% | +8.4% |
|
NMTC
NeuroOne Medical Technologies Corporation
Peer
|
-88.5% | -57.8% | +32.2% | -19.5% | +1.4% | -12.1% |
|
ATRA
Atara Biotherapeutics, Inc.
Peer
|
-98.9% | -95.6% | -24.7% | -54.9% | -70.3% | +15.0% |
|
BDMD
Baird Medical Investment Holdings Limited
Peer
|
-89.3% | -90.0% | -87.4% | -49.5% | -26.9% | -10.4% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
PLUR
Pluri Inc.
|
BEARISH | $35.28M | - | -% | -% | $3.51 | |
|
LGVN
Longeveron Inc.
|
BEARISH | $33.97M | - | -164.7% | -% | $1.16 | Compare |
|
NMTC
NeuroOne Medical...
|
BEARISH | $37.01M | - | -146.3% | -58.3% | $0.73 | Compare |
|
ATRA
Atara Biotherapeutics, Inc.
|
BEARISH | $37.64M | 1.83 | -% | 15.4% | $5.22 | Compare |
|
BDMD
Baird Medical Investment...
|
BEARISH | $37.83M | - | -8.0% | -10.0% | $1.03 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-08 | MANIEU ALEXANDRE WEINSTEIN | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award | 625,000 | $1,956,250 |
| 2025-12-04 | ABERMAN ZALMAN | Director | Stock Award | 346 | - |
| 2025-12-04 | YANAY YAKY | Chief Executive Officer | Stock Award | 6,588 | - |
| 2025-12-04 | SHEMESH-RASMUSSEN MAITAL | Director | Stock Award | 699 | - |
| 2025-12-04 | LEVI RAMI AVRAHAM | Director | Stock Award | 653 | - |
| 2025-12-04 | MANIEU ALEXANDRE WEINSTEIN | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award | 519 | - |
| 2025-12-04 | ZALTS LIAT | Chief Financial Officer | Stock Award | 3,660 | - |
| 2025-12-04 | AJCHENBAUM EITAN | Director | Stock Award | 668 | - |
| 2025-11-12 | AJCHENBAUM EITAN | Director | Stock Award | 11,685 | - |
| 2025-10-29 | MANIEU ALEXANDRE WEINSTEIN | Director and Beneficial Owner of more than 10% of a Class of Security | Option Exercise | 1,002,169 | $100 |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning PLUR from our newsroom.